This suggests that in comparison to MARCH3, MARCH8 is associated with a favorable prognosis in pancreatic cancer wherein higher MARCH8 expression correlated with better patient survival (Fig. EV4D,E). This evidence concerns the gene MARCHF8 and familial pancreatic carcinoma.